-+ 0.00%
-+ 0.00%
-+ 0.00%

CNS Pharmaceuticals Appoints Steve O'Loughlin CFO, Effective March 2, Succeeding Christopher Downs

Benzinga·02/17/2026 13:42:11
Listen to the news